A. Barsotti, F. Dini, and V. Nardini, From myocardial hypertrophy to heart failure: role of the interstitium], Cardiologia, vol.38, pp.67-77, 1993.

C. Brilla and B. Maisch, Regulation of the Structural Remodelling of the Myocardium: from Hypertrophy to Heart Failure, European Heart Journal, vol.15, issue.suppl D, pp.45-52, 1994.
DOI : 10.1093/eurheartj/15.suppl_D.45

K. Weber, C. Brilla, and S. Campbell, Regulatory Mechanisms of Myocardial Hypertrophy and Fibrosis: Results of in vivo Studies, Cardiology, vol.81, issue.4-5, pp.266-73, 1992.
DOI : 10.1159/000175816

B. Swynghedauw, Molecular Mechanisms of Myocardial Remodeling, Physiological Reviews, vol.269, issue.1, pp.215-62, 1999.
DOI : 10.1007/BF00586956

Y. Sun and K. Weber, Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones, Ann Med, vol.30, issue.1, pp.3-8, 1998.

T. Stork, M. Mockel, and O. Danne, Left ventricular hypertrophy and diastolic dysfunction: Their relation to coronary heart disease, Cardiovascular Drugs and Therapy, vol.6, issue.Suppl D, pp.533-540, 1995.
DOI : 10.1007/BF00877866

D. Castro, S. Caselli, S. Maron, and M. , Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study, Heart, vol.93, issue.2, pp.205-214, 2007.
DOI : 10.1136/hrt.2006.093997

S. Poulsen, Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction, Dan Med Bull, vol.48, pp.199-210, 2001.

K. Weber, Monitoring tissue repair and fibrosis from a distance, Circulation, vol.96, pp.2488-92, 1997.

D. Mann, Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future, Circulation Research, vol.91, issue.11, pp.988-98, 2002.
DOI : 10.1161/01.RES.0000043825.01705.1B

D. Mann, Tumor necrosis factor???induced signal transduction and left ventricular remodeling, Journal of Cardiac Failure, vol.8, issue.6
DOI : 10.1054/jcaf.2002.129253

A. Richards, M. Nicholls, and T. Yandle, Plasma N-Terminal Pro??Brain Natriuretic Peptide and Adrenomedullin : New Neurohormonal Predictors of Left Ventricular Function and Prognosis After Myocardial Infarction, Circulation, vol.97, issue.19, pp.1921-1930, 1998.
DOI : 10.1161/01.CIR.97.19.1921

E. Kotlyar, J. Vita, and M. Winter, The Relationship Between Aldosterone, Oxidative Stress, and Inflammation in Chronic, Stable Human Heart Failure, Journal of Cardiac Failure, vol.12, issue.2, pp.122-129, 2006.
DOI : 10.1016/j.cardfail.2005.08.005

R. Querejeta, N. Varo, and B. Lopez, Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease, Circulation, vol.101, issue.14, pp.1729-1764, 2000.
DOI : 10.1161/01.CIR.101.14.1729

J. Delyani, E. Robinson, and A. Rudolph, Effect of a selective aldosterone receptor antagonist in myocardial infarction, American Journal of Physiology-Heart and Circulatory Physiology, vol.240, issue.2, pp.647-54, 2001.
DOI : 10.1152/ajpendo.1995.269.4.E657

B. Pitt, N. Reichek, and R. Willenbrock, Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy: The 4E-Left Ventricular Hypertrophy Study, Circulation, vol.108, issue.15, pp.1831-1839, 2003.
DOI : 10.1161/01.CIR.0000091405.00772.6E

B. Schwartzkopff, M. Fassbach, and B. Pelzer, Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy, European Journal of Heart Failure, vol.33, issue.3, pp.439-443, 2002.
DOI : 10.1006/jmcc.2000.1321

P. Uusimaa, J. Risteli, and M. Niemela, Collagen Scar Formation After Acute Myocardial Infarction : Relationships to Infarct Size, Left Ventricular Function, and Coronary Artery Patency, Circulation, vol.96, issue.8, pp.2565-72, 1997.
DOI : 10.1161/01.CIR.96.8.2565

F. Zannad, A. F. Dousset, and B. , Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure, ACC Current Journal Review, vol.10, issue.3, pp.2700-2706, 2000.
DOI : 10.1016/S1062-1458(01)00256-2

R. Querejeta, B. Lopez, and A. Gonzalez, Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure, Circulation J Card Fail, vol.11014, pp.1263-8467, 2004.

D. Quilliot, A. F. Bohme, and P. , Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance, International Journal of Obesity, vol.25, issue.11, pp.1321-1329, 2005.
DOI : 10.1161/01.HYP.25.6.1155

F. Alla, A. Kearney-schwartz, and A. Radauceanu, Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes, European Journal of Heart Failure, vol.2, issue.suppl 2, pp.147-53, 2006.
DOI : 10.1002/jbmr.5650020510

S. Rehman, J. Januzzi, and J. , Natriuretic Peptide Testing in Clinical Medicine, Cardiology in Review, vol.16, issue.5, pp.240-249, 2008.
DOI : 10.1097/CRD.0b013e3181815333

R. Troughton and A. Richards, Outpatient Monitoring and Treatment of Chronic Heart Failure Guided by Amino-Terminal Pro???B-Type Natriuretic Peptide Measurement, The American Journal of Cardiology, vol.101, issue.3, pp.72-77, 2008.
DOI : 10.1016/j.amjcard.2007.11.027

H. Yasue, M. Yoshimura, and H. Sumida, Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure, Circulation, vol.90, issue.1, pp.195-203, 1994.
DOI : 10.1161/01.CIR.90.1.195

S. Masson, R. Latini, and I. Anand, Direct Comparison of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in a Large Population of Patients with Chronic and Symptomatic Heart Failure: The Valsartan Heart Failure (Val-HeFT) Data, Clinical Chemistry, vol.52, issue.8, pp.1528-1566, 2006.
DOI : 10.1373/clinchem.2006.069575

J. Steiner and M. Guglin, BNP or NTproBNP? A clinician's perspective, International Journal of Cardiology, vol.129, issue.1, p.29, 2008.
DOI : 10.1016/j.ijcard.2007.12.093

S. Waldo, J. Beede, and S. Isakson, Pro-B-Type Natriuretic Peptide Levels in Acute Decompensated Heart Failure, Journal of the American College of Cardiology, vol.51, issue.19, pp.1874-82, 2008.
DOI : 10.1016/j.jacc.2007.12.051

F. Hobbs, R. Davis, and A. Roalfe, Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations, Heart, vol.90, issue.8, pp.866-70, 2004.
DOI : 10.1136/hrt.2003.014258

P. Jourdain, G. Jondeau, and F. Funck, Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure, Journal of the American College of Cardiology, vol.49, issue.16, pp.1733-1742, 2007.
DOI : 10.1016/j.jacc.2006.10.081

J. Lainchbury, E. Campbell, and C. Frampton, Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath, Journal of the American College of Cardiology, vol.42, issue.4, pp.728-763, 2003.
DOI : 10.1016/S0735-1097(03)00787-3

I. Khan, J. Fink, and C. Nass, N-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide for Identifying Coronary Artery Disease and Left Ventricular Hypertrophy in Ambulatory Chronic Kidney Disease Patients, The American Journal of Cardiology, vol.97, issue.10, pp.1530-1534, 2006.
DOI : 10.1016/j.amjcard.2005.11.090

J. Magga, M. Puhakka, and S. Hietakorpi, Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction, Journal of Applied Physiology, vol.96, issue.4, pp.1306-1317, 2004.
DOI : 10.1161/01.HYP.33.4.961

URL : http://jap.physiology.org/content/jap/96/4/1306.full.pdf

L. Daniels, P. Clopton, and V. Bhalla, How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure, American Heart Journal, vol.151, issue.5, pp.999-1005, 2006.
DOI : 10.1016/j.ahj.2005.10.011

A. Richards, R. Troughton, and J. Lainchbury, Guiding and Monitoring of Heart Failure Therapy With NT-ProBNP: Concepts and Clinical Studies, Journal of Cardiac Failure, vol.11, issue.5, pp.34-41, 2005.
DOI : 10.1016/j.cardfail.2005.04.014

I. Squire, O. Brien, R. Demme, and B. , N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction, Clinical Science, vol.107, issue.3, pp.309-325, 2004.
DOI : 10.1042/CS20040087

M. Rivera, R. Talens-visconti, and A. Jordan, Remodelado mioc??rdico y activaci??n inmunitaria en pacientes con insuficiencia cardiaca, Revista Espa??ola de Cardiolog??a, vol.59, issue.9, pp.911-919, 2006.
DOI : 10.1157/13092799

M. Jimenez-navarro, J. Gomez-doblas, and F. Cabrera-bueno, Collagen Synthesis and Heart Failure, Revista Espa??ola de Cardiolog??a (English Edition), vol.58, issue.8, pp.975-983, 2005.
DOI : 10.1016/S1885-5857(06)60381-2

D. Fraccarollo, P. Galuppo, and J. Bauersachs, Mineralocorticoid Receptor Antagonism and Cardiac Remodeling in Ischemic Heart Failure, Current Medicinal Chemistry-Cardiovascular & Hematological Agents, vol.2, issue.4, pp.287-94, 2004.
DOI : 10.2174/1568016043356219

D. Kass, Ventricular dyssynchrony and mechanisms of resynchronization therapy, European Heart Journal Supplements, vol.4, issue.suppl_D, pp.23-3098, 2002.
DOI : 10.1054/jcaf.2000.9501

F. Masoudi, E. Havranek, and G. Smith, Gender, age, and heart failure with preserved left ventricular systolic function, Journal of the American College of Cardiology, vol.41, issue.2, pp.217-240, 2003.
DOI : 10.1016/S0735-1097(02)02696-7

J. Thambo, P. Bordachar, and S. Garrigue, Detrimental Ventricular Remodeling in Patients With Congenital Complete Heart Block and Chronic Right Ventricular Apical Pacing, Circulation, vol.110, issue.25, pp.3766-72, 2004.
DOI : 10.1161/01.CIR.0000150336.86033.8D

C. Yu, H. Lin, and Q. Zhang, High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration, Heart, vol.89, issue.1, pp.54-60, 2003.
DOI : 10.1136/heart.89.1.54

S. Baldasseroni, D. Biase, L. Fresco, and C. , Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database), European Heart Journal, vol.23, issue.21, pp.1692-1700, 2002.
DOI : 10.1053/euhj.2001.3157

G. Nelson, C. Curry, and B. Wyman, Predictors of Systolic Augmentation From Left Ventricular Preexcitation in Patients With Dilated Cardiomyopathy and Intraventricular Conduction Delay, Circulation, vol.101, issue.23, pp.2703-2712, 2000.
DOI : 10.1161/01.CIR.101.23.2703

K. Aaronson, J. Schwartz, and T. Chen, Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation, Circulation, vol.95, issue.12, pp.2660-2667, 1997.
DOI : 10.1161/01.CIR.95.12.2660

E. Agricola, M. Galderisi, and D. Mele, Mechanical dyssynchrony and functional mitral regurgitation: pathophysiology and clinical implications, Journal of Cardiovascular Medicine, vol.9, issue.5, pp.461-470, 2008.
DOI : 10.2459/JCM.0b013e3282ef39c5

E. Donal, D. Place, C. Kervio, and G. , Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony, European Journal of Echocardiography, vol.28, issue.1, p.51, 2008.
DOI : 10.1093/eurheartj/ehl379

URL : https://hal.archives-ouvertes.fr/hal-00911667

S. Iuliano, S. Fisher, and P. Karasik, QRS duration and mortality in patients with congestive heart failure, American Heart Journal, vol.143, issue.6, pp.1085-91, 2002.
DOI : 10.1067/mhj.2002.122516

J. Conti, Biventricular Pacing Therapy for Congestive Heart Failure: A Review of the Literature, Cardiology in Review, vol.9, issue.4, pp.217-243, 2001.
DOI : 10.1097/00045415-200107000-00008

W. Abraham, Cardiac Resynchronization Therapy for the Management of Chronic Heart Failure, The American Heart Hospital Journal, vol.7, issue.1
DOI : 10.1161/01.CIR.79.4.845

A. Achilli, M. Sassara, and S. Ficili, Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and ???narrow??? QRS, Journal of the American College of Cardiology, vol.42, issue.12, pp.2117-2141, 2003.
DOI : 10.1016/j.jacc.2003.08.024

M. Bristow, L. Saxon, and J. Boehmer, Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure, New England Journal of Medicine, vol.350, issue.21, pp.2140-50, 2004.
DOI : 10.1056/NEJMoa032423

C. Leclercq and D. Kass, Retiming the failing heart: principles and current clinical status of cardiac resynchronization, Journal of the American College of Cardiology, vol.39, issue.2, pp.194-201, 2002.
DOI : 10.1016/S0735-1097(01)01747-8

J. Fung, C. Yu, and G. Yip, Variable left ventricular activation pattern in patients with heart failure and left bundle branch block, Heart, vol.90, issue.1, pp.17-26, 2004.
DOI : 10.1136/heart.90.1.17

A. Duncan, D. Wait, and D. Gibson, Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC (Multisite Stimulationin Cardiomyopathies) trial,, European Heart Journal, vol.24, issue.5, pp.430-471, 2003.
DOI : 10.1016/S0195-668X(02)00475-X

C. Yu, E. Chau, and J. Sanderson, Tissue Doppler Echocardiographic Evidence of Reverse Remodeling and Improved Synchronicity by Simultaneously Delaying Regional Contraction After Biventricular Pacing Therapy in Heart Failure, Circulation, vol.105, issue.4, pp.438-483, 2002.
DOI : 10.1161/hc0402.102623

J. Cleland, J. Daubert, and E. Erdmann, The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure, New England Journal of Medicine, vol.352, issue.15, pp.1539-1588, 2005.
DOI : 10.1056/NEJMoa050496

M. Pitzalis, M. Iacoviello, and R. Romito, Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy, Journal of the American College of Cardiology, vol.45, issue.1, pp.65-998, 2005.
DOI : 10.1016/j.jacc.2004.09.058

C. Yu, J. Fung, and C. Chan, Comparison of Efficacy of Reverse Remodeling and Clinical Improvement for Relatively Narrow and Wide QRS Complexes After Cardiac Resynchronization Therapy for Heart Failure, Journal of Cardiovascular Electrophysiology, vol.11, issue.9, pp.1058-65, 2004.
DOI : 10.1016/S1388-9842(01)00176-3

D. Bradley, E. Bradley, and K. Baughman, Cardiac Resynchronization and Death From Progressive Heart Failure, JAMA, vol.289, issue.6, pp.730-770, 2003.
DOI : 10.1001/jama.289.6.730

W. Abraham, W. Fisher, and A. Smith, Cardiac resynchronization in chronic heart failure

J. Young, W. Abraham, and A. Smith, Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure, JAMA, vol.289, issue.20, pp.2685-94, 2003.
DOI : 10.1001/jama.289.20.2685

E. Donal, C. Leclercq, and C. Linde, Effects of cardiac resynchronization therapy on disease progression in chronic heart failure, European Heart Journal, vol.42, issue.9, pp.1018-1043, 2006.
DOI : 10.1016/j.jacc.2003.04.003

L. Pires, W. Abraham, and J. Young, Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials, American Heart Journal, vol.151, issue.4, pp.837-880, 2006.
DOI : 10.1016/j.ahj.2005.06.024

C. Yu, J. Fung, and Q. Zhang, Tissue Doppler Imaging Is Superior to Strain Rate Imaging and Postsystolic Shortening on the Prediction of Reverse Remodeling in Both Ischemic and Nonischemic Heart Failure After Cardiac Resynchronization Therapy, Circulation, vol.110, issue.1, pp.66-73, 2004.
DOI : 10.1161/01.CIR.0000133276.45198.A5

C. Yu, W. Abraham, and J. Bax, Predictors of response to cardiac resynchronization therapy (PROSPECT)???study design, American Heart Journal, vol.149, issue.4, pp.600-605, 2005.
DOI : 10.1016/j.ahj.2004.12.013

C. Yu, Q. Zhang, and J. Fung, A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging, Journal of the American College of Cardiology, vol.45, issue.5, pp.677-84, 2005.
DOI : 10.1016/j.jacc.2004.12.003

N. Hawkins, M. Petrie, and M. Macdonald, Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?, European Heart Journal, vol.27, issue.4, pp.1270-81, 2006.
DOI : 10.1111/j.1540-8159.2004.00433.x

URL : https://academic.oup.com/eurheartj/article-pdf/27/11/1270/1237828/ehi826.pdf

P. Sogaard, H. Egeblad, and W. Kim, Tissue doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy, Journal of the American College of Cardiology, vol.40, issue.4, pp.723-753, 2002.
DOI : 10.1016/S0735-1097(02)02010-7

E. Chung, A. Leon, and L. Tavazzi, Results of the Predictors of Response to CRT (PROSPECT) Trial, Circulation, vol.117, issue.20, pp.2608-2624, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.743120

F. Fruhwald, A. Fahrleitner-pammer, and R. Berger, Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony, European Heart Journal, vol.28, issue.13, pp.1592-1599, 2007.
DOI : 10.1093/eurheartj/ehl505

M. Vanderheyden, W. Mullens, and L. Delrue, Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy, Journal of the American College of Cardiology, vol.51, issue.2, pp.129-165, 2008.
DOI : 10.1016/j.jacc.2007.07.087

URL : https://doi.org/10.1016/j.jacc.2007.07.087

I. Garcia-bolao, B. Lopez, and A. Macias, Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy, European Heart Journal, vol.29, issue.7, pp.898-906, 2008.
DOI : 10.1093/eurheartj/ehn098

J. Diez, C. Laviades, and G. Mayor, Increased Serum Concentrations of Procollagen Peptides in Essential Hypertension : Relation to Cardiac Alterations, Circulation, vol.91, issue.5, pp.1450-1456, 1995.
DOI : 10.1161/01.CIR.91.5.1450

N. Host, L. Jensen, and P. Bendixen, The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction, The American Journal of Cardiology, vol.76, issue.12, pp.869-73, 1995.
DOI : 10.1016/S0002-9149(99)80251-3

F. Spinale, M. Coker, and L. Heung, A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure, Circulation, vol.102, issue.16, pp.1944-1953, 2000.
DOI : 10.1161/01.CIR.102.16.1944

M. Eghbali and K. Weber, Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression, Molecular and Cellular Biochemistry, vol.96, issue.1, pp.1-14, 1990.
DOI : 10.1007/BF00228448

B. Jugdutt, Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways, Current Drug Target -Cardiovascular & Hematological Disorders, vol.3, issue.1, pp.1-3098, 2003.
DOI : 10.2174/1568006033337276

M. Cicoira, A. Rossi, and S. Bonapace, Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure, Journal of Cardiac Failure, vol.10, issue.5, pp.403-414, 2004.
DOI : 10.1016/j.cardfail.2004.01.010

Y. Lin, Y. Chiu, and Y. Shiau, The relation between serum level of amioterminal propeptide of type I procollagen and diastolic dysfunction in hypertensive patients without diabetes mellitus: a pilot study, Journal of Human Hypertension, vol.35, issue.12, pp.964-971, 2006.
DOI : 10.1111/j.1365-2362.2005.01438.x

M. Olsen, M. Christensen, and K. Wachtell, Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy, Journal of Human Hypertension, vol.2, issue.Suppl, pp.301-308, 2005.
DOI : 10.1097/00043798-199502000-00003

T. Murakami, S. Kusachi, and M. Murakami, Time-dependent changes of serum carboxyterminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices, Clin Chem, vol.44, pp.2453-61, 1998.

T. Kitahara, Y. Takeishi, and T. Arimoto, Serum Carboxy-Terminal Telopeptide of Type I Collagen (ICTP) Predicts Cardiac Events in Chronic Heart Failure Patients With Preserved Left Ventricular Systolic Function, Circulation Journal, vol.71, issue.6, pp.929-964, 2007.
DOI : 10.1253/circj.71.929

S. Ahmed, L. Clark, and W. Pennington, Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease, Circulation, vol.113, issue.17, pp.2089-96, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.573865

B. Pitt, F. Zannad, and W. Remme, The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure, New England Journal of Medicine, vol.341, issue.10, pp.709-726, 1999.
DOI : 10.1056/NEJM199909023411001

A. Bruggink, M. Van-oosterhout, and N. De-jonge, Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium, J Heart Lung Transplant Eur Heart J, vol.2527, pp.1091-8201, 2006.

J. Cleland, J. Daubert, and E. Erdmann, The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points, European Journal of Heart Failure, vol.16, issue.4, pp.481-490, 2001.
DOI : 10.1016/S0197-2456(95)00132-8

K. Ellenbogen, M. Wood, and H. Klein, Why Should We Care About CARE-HF?, Journal of the American College of Cardiology, vol.46, issue.12, pp.2199-203, 2005.
DOI : 10.1016/j.jacc.2005.07.057

URL : https://doi.org/10.1016/j.jacc.2005.07.057

J. Cleland, J. Daubert, and E. Erdmann, Baseline characteristics of patients recruited into the CARE-HF study, European Journal of Heart Failure, vol.7, issue.2, pp.205-219, 2005.
DOI : 10.1016/j.ejheart.2005.01.012

M. Calvert, N. Freemantle, and G. Yao, Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial, European Heart Journal, vol.26, issue.24, pp.2681-2689, 2005.
DOI : 10.1007/s10198-004-0264-z

J. Cleland, J. Daubert, and E. Erdmann, Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase], European Heart Journal, vol.27, issue.16, pp.1928-1960, 2006.
DOI : 10.1093/eurheartj/ehl099

A. Levey, J. Coresh, and E. Balk, National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification, Annals of Internal Medicine, vol.139, issue.2, pp.137-184, 2003.
DOI : 10.7326/0003-4819-139-2-200307150-00013

URL : http://annals.org/data/journals/aim/20044/0000605-200307150-00013.pdf

P. Whittaker, D. Boughner, and R. Kloner, Analysis of healing after myocardial infarction using polarized light microscopy, Am J Pathol, vol.134, pp.879-93, 1989.

L. Jensen, K. Horslev-petersen, and P. Toft, Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction, Circulation, vol.81, issue.1, pp.52-59, 1990.
DOI : 10.1161/01.CIR.81.1.52

URL : http://circ.ahajournals.org/content/circulationaha/81/1/52.full.pdf

Y. Sun and K. Weber, Infarct scar: a dynamic tissue, Cardiovascular Research, vol.46, issue.2, pp.250-256, 2000.
DOI : 10.1016/S0008-6363(00)00032-8

URL : https://academic.oup.com/cardiovascres/article-pdf/46/2/250/1157228/46-2-250.pdf

I. Willems, M. Havenith, D. Mey, and J. , The alpha-smooth muscle actin-positive cells in healing human myocardial scars, Am J Pathol, vol.145, issue.101, pp.868-75, 1994.

F. Spinale, Matrix Metalloproteinases: Regulation and Dysregulation in the Failing Heart, Circulation Research, vol.90, issue.5, pp.520-550, 2002.
DOI : 10.1161/01.RES.0000013290.12884.A3

N. Anavekar, J. Mcmurray, and E. Velazquez, Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction, New England Journal of Medicine, vol.351, issue.13, pp.1285-9598, 2004.
DOI : 10.1056/NEJMoa041365

R. De-silva, A. Rigby, and K. Witte, Anemia, Renal Dysfunction, and Their Interaction in Patients With Chronic Heart Failure, The American Journal of Cardiology, vol.98, issue.3, pp.391-399, 2006.
DOI : 10.1016/j.amjcard.2006.01.107

A. Radauceanu, F. Moulin, and W. Djaballah, Residual stress ischaemia is associated with blood markers of myocardial structural remodelling, European Journal of Heart Failure, vol.23, issue.4, pp.370-376, 2007.
DOI : 10.1097/01.hjh.0000173780.67308.f1

G. Klappacher, P. Franzen, and D. Haab, Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis, The American Journal of Cardiology, vol.75, issue.14
DOI : 10.1016/S0002-9149(99)80686-9

M. Richardson, N. Freemantle, and M. Calvert, Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial, European Heart Journal, vol.28, issue.15, pp.1827-1861, 2007.
DOI : 10.1093/eurheartj/ehm192

W. Iraqi, P. Rossignol, and R. Fay, Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the EPHESUS study Article submitted in Circulation 112 http://www.cardiodiac.net/PaceMaker, pp.2-67546

F. Zannad, P. Rossignol, and W. Iraqi, Extracellular matrix fibrotic markers in heart failure Article submitted